Task: Answer the multiple-choice question.
Query: Which drug exhibits a -5.271% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CC12C(=O)N(c3ccccc3)C(=O)C1C(c1ccccc1)N1CCCN12
b.) Cc1ccc(/C=C/C(=O)OC(C)C(=O)Nc2ncc(Cl)cc2Cl)o1
c.) CCN(CCO)Cc1csc2ccccc12.Cl
d.) CCCCN(C(=O)c1cc2ccccc2o1)c1c(N)n(CCC)c(=O)[nH]c1=O
e.) CCn1c(SCC(=O)N2CCCCC2)nnc1-c1ccc(S(=O)(=O)N2CCN(C)CC2)cc1
Answer: d. CCCCN(C(=O)c1cc2ccccc2o1)c1c(N)n(CCC)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C(=O)c1cc2ccccc2o1)c1c(N)n(CCC)c(=O)[nH]c1=O
CCCCN(C(=O)c1cc2ccccc2o1)c1c(N)n(CCC)c(=O)[nH]c1=O
N-(6-amino-2,4-dioxo-1-propylpyrimidin-5-yl)-N-butyl-1-benzofuran-2-carboxamide